Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The BTG3 associated nuclear protein pseudogene (ENSG00000260413) is a genetic locus that closely resembles the sequence of the functional BTG3 associated nuclear protein gene but contains disruptions—such as premature stop codons or deletions—that prevent it from producing a functional protein product[1][2][5]. Pseudogenes are typically classified as nonfunctional genomic elements, although some have been shown to play regulatory roles through RNA-mediated mechanisms such as acting as microRNA "sponges"[4][7]. There is no evidence that ENSG00000260413 encodes a functional protein or serves as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BTG3 associated nuclear protein pseudogene.